Dr. Anuradha Anand, M.D. Physical Medicine & Rehabilitation Medicare: May Accept Medicare Assignments Practice Location: 310 Seven Fields Blvd Ste 130, Seven Fields, PA 16046 Phone: 724-308-7401 Fax: 724-933-0091 |
News Archive
Though researchers are becoming increasingly aware of the long-term effects of head injury, few studies have looked at the prevalence of traumatic brain injury (TBI) in all age groups, including males and females, taking into account both mild and serious events. In a recent study published in Epidemiology, Mayo Clinic researchers applied a new, refined system for classifying injuries caused by force to the head and found that the incidence of traumatic brain injury is likely greater than has been estimated by the Centers for Disease Control and Prevention.
The proposed spending bill includes language preventing the use of federal dollars to "implement, administer or further" the Affordable Care Act. A number of other programs and agencies - including the Agency for Healthcare Research and Quality - are targeted for termination.
Scientists are reporting discovery of a potential new drug for epidemic keratoconjunctivitis (EKC) - sometimes called "pink eye" - a highly infectious eye disease that may occur in 15 million to 20 million people annually in the United States alone. Their report describing an innovative new "molecular wipe" that sweeps up viruses responsible for EKC appears in ACS's Journal of Medicinal Chemistry.
ACCESS PHARMACEUTICALS, INC., a biopharmaceutical company leveraging its proprietary drug-delivery platforms to develop treatments in areas of oncology, diabetes, and RNAi, announced that its MuGard partner in China, RHEI Pharmaceuticals has received the acceptance letter from the State Food and Drug Administration (SFDA) of China acknowledging all necessary documentation for the MuGard has been submitted and accepted.
› Verified 8 days ago